189 related articles for article (PubMed ID: 37931072)
1. Synthesis and Characterization of Paclitaxel-Loaded PEGylated Liposomes by the Microfluidics Method.
Jaradat E; Weaver E; Meziane A; Lamprou DA
Mol Pharm; 2023 Dec; 20(12):6184-6196. PubMed ID: 37931072
[TBL] [Abstract][Full Text] [Related]
2. Microfluidic paclitaxel-loaded lipid nanoparticle formulations for chemotherapy.
Jaradat E; Weaver E; Meziane A; Lamprou DA
Int J Pharm; 2022 Nov; 628():122320. PubMed ID: 36272514
[TBL] [Abstract][Full Text] [Related]
3. Conventional vs PEGylated loaded liposomal formulations by microfluidics for delivering hydrophilic chemotherapy.
Jaradat E; Meziane A; Lamprou DA
Int J Pharm; 2024 Apr; 655():124077. PubMed ID: 38569975
[TBL] [Abstract][Full Text] [Related]
4. High throughput microfluidics-based synthesis of PEGylated liposomes for precise size control and efficient drug encapsulation.
Akar S; Fardindoost S; Hoorfar M
Colloids Surf B Biointerfaces; 2024 Jun; 238():113926. PubMed ID: 38677154
[TBL] [Abstract][Full Text] [Related]
5. Sterically stabilized liposomes production using staggered herringbone micromixer: Effect of lipid composition and PEG-lipid content.
Cheung CCL; Al-Jamal WT
Int J Pharm; 2019 Jul; 566():687-696. PubMed ID: 31212051
[TBL] [Abstract][Full Text] [Related]
6. Preparation, optimization, and characterization of topotecan loaded PEGylated liposomes using factorial design.
Vali AM; Toliyat T; Shafaghi B; Dadashzadeh S
Drug Dev Ind Pharm; 2008 Jan; 34(1):10-23. PubMed ID: 18214751
[TBL] [Abstract][Full Text] [Related]
7. Rapid scale-up and production of active-loaded PEGylated liposomes.
Roces CB; Port EC; Daskalakis NN; Watts JA; Aylott JW; Halbert GW; Perrie Y
Int J Pharm; 2020 Aug; 586():119566. PubMed ID: 32622812
[TBL] [Abstract][Full Text] [Related]
8. Development of paclitaxel loaded pegylated gelatin targeted nanoparticles for improved treatment efficacy in non-small cell lung cancer (NSCLC): an in vitro and in vivo evaluation study.
Gu M; Luan J; Song K; Qiu C; Zhang X; Zhang M
Acta Biochim Pol; 2021 Aug; 68(4):583-591. PubMed ID: 34355554
[TBL] [Abstract][Full Text] [Related]
9. Microfluidic synthesis of PEG- and folate-conjugated liposomes for one-step formation of targeted stealth nanocarriers.
Hood RR; Shao C; Omiatek DM; Vreeland WN; DeVoe DL
Pharm Res; 2013 Jun; 30(6):1597-607. PubMed ID: 23386106
[TBL] [Abstract][Full Text] [Related]
10. Co-loaded paclitaxel/rapamycin liposomes: Development, characterization and in vitro and in vivo evaluation for breast cancer therapy.
Eloy JO; Petrilli R; Topan JF; Antonio HMR; Barcellos JPA; Chesca DL; Serafini LN; Tiezzi DG; Lee RJ; Marchetti JM
Colloids Surf B Biointerfaces; 2016 May; 141():74-82. PubMed ID: 26836480
[TBL] [Abstract][Full Text] [Related]
11. Preparation, Characterization, and In Vitro Pharmacodynamics and Pharmacokinetics Evaluation of PEGylated Urolithin A Liposomes.
Yi S; Zhang C; Hu J; Meng Y; Chen L; Yu H; Li S; Wang G; Zheng G; Qiu Z
AAPS PharmSciTech; 2021 Jan; 22(1):26. PubMed ID: 33404864
[TBL] [Abstract][Full Text] [Related]
12. Microfluidic-assisted nanoprecipitation of (PEGylated) poly (d,l-lactic acid-co-caprolactone): Effect of macromolecular and microfluidic parameters on particle size and paclitaxel encapsulation.
Lallana E; Donno R; Magrì D; Barker K; Nazir Z; Treacher K; Lawrence MJ; Ashford M; Tirelli N
Int J Pharm; 2018 Sep; 548(1):530-539. PubMed ID: 30009983
[TBL] [Abstract][Full Text] [Related]
13. Pegylated liposome encapsulating docetaxel using microfluidic mixing technique: Process optimization and results in breast cancer models.
Dacos M; Immordino B; Diroff E; Sicard G; Kosta A; Rodallec A; Giacometti S; Ciccolini J; Fanciullino R
Int J Pharm; 2024 May; 656():124091. PubMed ID: 38588758
[TBL] [Abstract][Full Text] [Related]
14. Lyophilization of cholesterol-free PEGylated liposomes and its impact on drug loading by passive equilibration.
Chaudhury A; Das S; Lee RF; Tan KB; Ng WK; Tan RB; Chiu GN
Int J Pharm; 2012 Jul; 430(1-2):167-75. PubMed ID: 22537806
[TBL] [Abstract][Full Text] [Related]
15. Controlling lamellarity and physicochemical properties of liposomes prepared using a microfluidic device.
Matsuura-Sawada Y; Maeki M; Uno S; Wada K; Tokeshi M
Biomater Sci; 2023 Mar; 11(7):2419-2426. PubMed ID: 36752548
[TBL] [Abstract][Full Text] [Related]
16. Rapid optimization of liposome characteristics using a combined microfluidics and design-of-experiment approach.
Sedighi M; Sieber S; Rahimi F; Shahbazi MA; Rezayan AH; Huwyler J; Witzigmann D
Drug Deliv Transl Res; 2019 Feb; 9(1):404-413. PubMed ID: 30306459
[TBL] [Abstract][Full Text] [Related]
17. Stealth Liposomes (PEGylated) Containing an Anticancer Drug Camptothecin: In Vitro Characterization and In Vivo Pharmacokinetic and Tissue Distribution Study.
Sivadasan D; Sultan MH; Madkhali OA; Alsabei SH; Alessa AA
Molecules; 2022 Feb; 27(3):. PubMed ID: 35164350
[TBL] [Abstract][Full Text] [Related]
18. PEGylated Liposomes of Meloxicam: Optimization by Quality by Design, in vitro Characterization and Cytotoxicity Evaluation.
Shaji J; Menon I
Pharm Nanotechnol; 2017; 5(2):119-137. PubMed ID: 28462699
[TBL] [Abstract][Full Text] [Related]
19. Graphene oxide stabilized by PLA-PEG copolymers for the controlled delivery of paclitaxel.
Angelopoulou A; Voulgari E; Diamanti EK; Gournis D; Avgoustakis K
Eur J Pharm Biopharm; 2015 Jun; 93():18-26. PubMed ID: 25817600
[TBL] [Abstract][Full Text] [Related]
20. The preparation, characterization of Lupeol PEGylated liposome and its functional evaluation
Zhang J; Liang H; Yao H; Qiu Z; Chen X; Hu X; Hu J; Zheng G
Drug Dev Ind Pharm; 2019 Jul; 45(7):1052-1060. PubMed ID: 30939950
[No Abstract] [Full Text] [Related]
[Next] [New Search]
